In HIV-1 vertically infected infants, starting antiretroviral therapy before the age of 3 months is associated with a significant reduction in progression to AIDS and death.
Goetghebuer, T., Haelterman, E., Le Chenadec, J., Dollfus, C., Gibb, D., Judd, A., Green, H., Galli, L., Ramos, J. T., Giaquinto, C., Warszawski, J., Levy, J., & Van der Linden, D. (2009). Effect of early antiretroviral therapy on the risk of AIDS/death in HIV-infected infants. AIDS. https://doi.org/10.1097/QAD.0b013e328326ca37